Effects of two oral contraceptives on plasma levels of nitric oxide, homocysteine, and lipid metabolism

This prospective study was performed to investigate the effect of 2 low-dose oral contraceptives containing a second- and a third-generation progestagen on factors, which may influence the individual cardiovascular risk by regulating endothelial function and development of atherosclerosis. Sixteen w...

Full description

Saved in:
Bibliographic Details
Published in:Metabolism, clinical and experimental clinical and experimental, 2002-09, Vol.51 (9), p.1216-1221
Main Authors: Merki-Feld, Gabriele S., Imthurn, Bruno, Keller, Paul J.
Format: Article
Language:English
Subjects:
Adult
Biological and medical sciences
Cholesterol - blood
Contraceptives, Oral - pharmacology
Contraceptives, Oral, Synthetic - pharmacology
Drug Combinations
Drug toxicity and drugs side effects treatment
Ethinyl Estradiol - pharmacology
Female
Homocysteine - blood
Humans
Levonorgestrel - pharmacology
Lipid Metabolism
Lipoproteins - blood
Medical sciences
Miscellaneous (drug allergy, mutagens, teratogens...)
Nitric Oxide - blood
Norpregnenes - pharmacology
Pharmacology. Drug treatments
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This prospective study was performed to investigate the effect of 2 low-dose oral contraceptives containing a second- and a third-generation progestagen on factors, which may influence the individual cardiovascular risk by regulating endothelial function and development of atherosclerosis. Sixteen women were randomized to receive 3 cycles of treatment with 30 [mu ]g ethinylestradiol/150 [mu ]g levonorgestrel (EE/LNG) and 3 cycles of treatment with 30 [mu ]g ethinylestradiol/75 [mu ]g gestodene (EE/GSD). Before and after treatment the plasma levels of nitric oxide (NO), homocysteine, cholesterol, high-density lipoprotein (HDL), and triglycerides were measured. No significant alterations of the NO, homocysteine, and triglyceride plasma levels were observed during use of both contraceptive pills. Compared to levels after EE/LNG treatment, HDL plasma levels were higher (P = .05) and the cholesterol/HDL ratio was lower after the EE/GSD pill (P = .05). Significant correlations were found between NO and homocysteine and NO and cholesterol. Our data indicate that the cardiovascular risk associated with these contraceptive pills may not be explained by a negative influence on NO or homocysteine.
ISSN:0026-0495
1532-8600
DOI:10.1053/meta.2002.34038